July 25, 2018 / 6:26 AM / 3 months ago

Indivior warns of bigger hit from copycat drug

July 25 (Reuters) - Indivior said on Wednesday the impact from the launch of a generic version of its opioid addiction treatment "could be materially higher" in 2018, as the British drugmaker posted a second straight drop in quarterly profit.

The company, which issued a profit warning this month citing significant market share loss for star drug Suboxone Film, said adjusted net income fell 21.3 percent to $70 million in the quarter ended June 30 from a year earlier.

Revenue fell 6.9 percent to $268 million in the quarter. (Reporting by Justin George Varghese in Bengaluru Editing by Saumyadeb Chakrabarty)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below